Tag: Motley Fool

  • Why BPH Energy (ASX:BPH) shares are in a trading halt

    pause button on digital screen representing asx trading pause

    Today BPH Energy Ltd (ASX: BPH) shares were placed in a trading halt after the company announced it is planning on undertaking a capital raising. At the close of market on Friday, the BPH share price was sitting at 17 cents.

    The small-cap ASX share also released its quarterly activities and cash flow reports to the market today.

    Trading halt

    Today BPH Energy shares were placed in a trading halt at the request of the company “for the purpose of considering, planning and executing a capital raising”.

    The company has requested its shares remain in the trading halt until either the announcement is made or before the commencement of normal trading on 3 February. BPH Energy further advised it expected the announcement will be made before Wednesday.

    It’s possible the funds will be used on the company’s interests in the Sydney Basin mentioned below.

    Operations report

    During the quarter, Advent Energy, of which BPH is a substantial shareholder, submitted an application to the National Offshore Petroleum Titles Administrator (NOPTA). The application was a request to enable drilling of the Baleen drill target in the PEP11 permit offshore from Newcastle, New South Wales. The PEP11 joint venture has reviewed the work program and now expects to proceed with the drilling of a well as soon as the approvals from NOPTA and other authorities are received. This project still requires financing.

    BPH energy is proposing with its partner, Bounty Oil & Gas NL (ASX: BUY), to use the drilling program at Baleen to investigate the potential for carbon, capture and storage (CCS) in the works. CCS is a process that can capture carbon dioxide fossil fuel emissions. Both the International Energy Agency and the Intergovernmental Panel on Climate Change believe that CCS can play an important role in helping to meet global emission reduction targets. To this end, during the quarter, BPH appointed earth scientist Peter Cook as an advisor for CCS.

    On an interesting side note, Sydney Basin projects are major contributors to Australia’s greenhouse gas emissions and currently contribute up to 34% of our total national emissions.

    About the BPH Energy share price

    Whilst BPH Energy shares remain in a trading halt, according to Commsec they are expected to open 5.88% higher to a price of 18 cents when trading resumes.

    The BPH Energy share price was also rocketing higher last week, gaining 165% for the week by Friday’s market close.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why BPH Energy (ASX:BPH) shares are in a trading halt appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3cpn34d

  • Here’s why the Orbital (ASX:OEC) share price has tumbled 20% today

    A businessman holds his glasses in concern, indicating uncertainly in the ASX share price

    The Orbital Corporation Ltd (ASX: OEC) share price is among the worst performers on the ASX market today, plunging from $1.04 to a low of 81 cents in opening trade.

    At the time of writing, the company’s shares have clawed back some ground and are now trading at 90 cents, down 20%.

    This, after the advanced aerospace manufacturer provided investors with a business update on its preliminary results for the first half of FY21.

    What did Orbital announce?

    In today’s release, Orbital advised it achieved preliminary revenue of $19 million for the six months ending 31 December 2020. The company attributed this 67% increase on the prior corresponding period to strong output from its two engine production lines.

    Orbital is the primary engine supplier for tactical unmanned aerial vehicles to Insitu Inc – a subsidiary of global behemoth, Boeing Co (NYSE: BA). Orbital runs operations in both Australia, and the United States.

    Orbital CEO and managing director, Todd Alder, commented:

    Throughout 2020 we proactively managed the additional risks brought about by COVID-19, managing our global supply chain and distribution network and implementing measures within our operations to keep our teams safe while continuing to manufacture.

    So, what’s sinking the Orbital share price?

    With the positive news at the top of the release, Orbital went on to mention that it has revised its 2021 full-year revenue guidance. The adjustment is due to Insitu Inc requiring a drop in production volumes from one of the two engine models. Recent challenging market conditions caused by COVID-19 were blamed for what will be a loss of potential revenue to the company.

    As a result, Orbital altered its production targets up until June 2021. Revised revenue guidance for the FY21 is expected to fall between $30 million and $40 million.

    Mr Alder touched on the renewed update, saying:

    Taking into consideration reduced customer requirements, we have revised our forecast production targets for the second half of FY21. While this adjustment to our production schedule is regrettable, we continue to manufacture and progress our deliverables under the existing long term supply agreement with Insitu.

    It’s worth noting that, Orbital has two of five engine models currently in production with Insitu Inc. A third engine model is currently in the development stage. It’s anticipated that the upcoming engine will be ready for production in Q4 FY21 at its Western Australia facility.

    Customer diversification

    To avoid stunted growth, the company is focused on diversifying its customer base. Orbital has been busy at work with Northrop Grumman and one of Singapore’s largest defence companies on engine development programs. It has scheduled the engine protypes to be sent to its retrospective customers in 2021 for further testing.

    Said Mr Alder:

    We continue to make good progress with our existing engine development programs and are advancing negotiations on additional Tier 1 defence opportunities.

    With our superior heavy fuel patented technology and the current market opportunities that exist, we are confident in our ability to build our global customer base and create an exciting platform for long term growth in the rapidly evolving UAV industry.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Orbital Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Here’s why the Orbital (ASX:OEC) share price has tumbled 20% today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3pBMu69

  • 2 compelling ASX shares to buy in February 2021

    wooden blocks with percentage signs being built into towers of increasing height

    There are some ASX shares that may be quite compelling to investors at the moment.

    Businesses that are able to grow their revenue at a fast pace and increase the profit margin may be able to grow the net profit after tax at a pleasing speed.

    That’s why it could be worth keeping an eye on these two ASX shares:

    Kogan.com Ltd (ASX: KGN)

    At the current Kogan.com share price, it’s valued at 24x FY23’s estimated earnings according to Commsec.

    The company is taking advantage of the structural shift to online shopping by consumers. 

    Kogan.com can offer them a wide array of products from categories like TVs, computers, phones, cameras, drones, heating and cooling, other appliances, furniture, office supplies, toys, cars and so on. Kogan.com also has other household services such as mobile, internet, energy, credit cards, insurance and superannuation.

    The ASX share also has a membership service called Kogan First which offers benefits like free shipping.

    Mr Kogan, the founder of the company, has previously spoken about the benefit to the company of its growing number of people using its loyalty scheme at the FY20 result: “The Kogan First community of members grew exceptionally during the second half, and importantly these loyal members on average purchase and save much more often than non-members, demonstrating loyalty to the platform, and also demonstrating the significant savings and other benefits available through the loyalty program.”

    The growing number of customers is helping grow Kogan.com’s sales and margins.

    In FY20 Kogan.com reported that its active customer base jumped 35.7% to 2.18 million. FY20 gross sales went up 39.3% to $768.9 million, gross profit rose 39.6% to $126.5 million, adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) climbed 57.6% and net profit after tax grew 55.9% to $26.8 million.

    The EBITDA margin has been consistently rising. In FY17 it was 4.3% and by FY20 it had grown to 9.3%.

    That growth has continued into the first half of FY21. In an update last week the ASX share said that gross sales grew 96%, gross profit jumped 120% and EBITDA went up 140%. It finished with 3 million active customers.

    Pushpay Holdings Ltd (ASX: PPH)

    Pushpay is another ASX share that has seen rocketing revenue and even quicker profit growth.

    According to Commsec, the Pushpay share price is valued at 22x FY23’s estimated earnings.

    The electronic donation business is experiencing even greater levels of donations passing through its systems.

    In the FY21 half-year result it said that total processing volume went up by 48% to US$3.2 billion. In that same result, operating revenue went up 53% to US$85.6 million, the gross margin improved by 3 percentage points to 68% and net profit after tax went up 107% to US$13.4 million. Operating cashflow increased by 203% to US$27 million.  

    One of the biggest increases in the report was the improvement of the earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) margin by 14 percentage points from 17% to 31%.

    Over the long-term the ASX share is aiming for a 50% market share of the large and medium US church sector, which may translate into US$1 billion of annual revenue.

    In a recent update the company said that it was upgrading its EBITDAF guidance for FY21 again, to a range of between US$56 million to US$60 million.

    It also said that it has made an initial allocation of investment resources into developing and enhancing the customer proposition for the Catholic segment of the US faith sector.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Kogan.com ltd and PUSHPAY FPO NZX. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 compelling ASX shares to buy in February 2021 appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ozRRBF

  • Why the Advance NanoTek (ASX:ANO) share price is sinking lower again

    Red and white arrows showing share price drop

    The Advance NanoTek Ltd (ASX: ANO) share price has started the week with a day in the red.

    In morning trade, the advanced materials company’s shares were down as much 9% to $3.61.

    The Advance NanoTek share price has since rebounded but is still down 2% to $3.90 in late afternoon trade.

    Why is the Advance NanoTek share price sinking lower?

    Investors have been selling Advance NanoTek shares on Monday following the release of an update on its first half performance.

    According to the release, as the company had previously warned, it is expecting to post the smallest of profits for the six months ended 31 December.

    Subject to its audit, Advance NanoTek recorded a half year result profit before tax of $90,000. This compares to a net profit before tax of $4.81 million in the prior corresponding period.

    Management advised that this weak result has been driven by travel restrictions and lockdowns caused by COVID-19. This has led to a reduction in sunscreen sales globally and therefore lower demand for the company’s zinc oxide which goes inside these products.

    What about current trading?

    Within the release, the company listed a number of “good news” items. One of those is that it has witnessed an improvement in its performance during January.

    It advised that it has experienced a significant increase in sales orders, leading to the company recording an unaudited profit before tax of $540,000 for the month.

    In addition to this, the company revealed that it has been working on a number of new products which it hopes to release in the near future. It expects these to have a positive impact on its FY 2022 results.

    It explained: “ANO has successfully developed 15 new bulk intermediate products, vegan and/or organic based, including an all natural insect repellent. Once our TGA licence is obtained, ANO will begin full scale production of the products.”

    “Samples are being prepared for our distributors and ANO anticipates sales of these products to impact our results in FY22. In addition, we are working on a premium range of dispersions based on our current dispersions and we expect these to be available to distributors and customers in FY22,” it added.

    Looking ahead, management appears to believe the future will be bright once the pandemic passes.

    It concluded: “The Board would like to point out that most of the achievements listed under the Good News heading are likely to produce positive results for many years to come, on the other hand, the Bad News, COVID-19 issues are likely to be resolved over the next two years.”

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Advance NanoTek Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Advance NanoTek (ASX:ANO) share price is sinking lower again appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3j5e2hW

  • Forget growth or value: Here’s a neutral way to pick shares

    Redpoint chief executive Max Cappetta

    Ask A Fund Manager

    The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, Redpoint chief executive Max Cappetta tells how quantitative investing saves choosing between growth or value.

     

    Investment style

    The Motley Fool: What’s your fund’s philosophy?

    Max Cappetta: The name of the fund is the Generation Life Tax Aware Australian Share Fund. Redpoint, we are the underlying manager to that strategy. 

    It is a strategy run specifically and exclusively for Generation Life as part of their investment bond offering. It’s a 30% tax-paid investment structure that if investors hold for up to 10 years, then the proceeds of that investment are tax-free in their hands and there’s no annual distributions. So there’s no taxable income events throughout the period that you’re invested in the bond.

    Investment bonds have been around for decades. But I think they’re really finding a Renaissance at the moment with limits to superannuation and for people just looking for more tax effective ways to save for major expenditures throughout their life.

    MF: What’s the investment strategy?

    MC: A couple of key things. Number one, we’re quantitative investors – that means that we actually generally don’t meet with company management, and we actually model the financial statements and a range of other metrics. 

    The reason we do that is because we realised that no one investment style or discipline is consistently rewarded. Styles come in and out of favour. For example, if you’d been a value-focused manager over the last few years, it’s been a very tough environment. If you’ve been more of a growth manager, you’ve had a much better time. 

    We want to build a portfolio using insights from each company’s financial statements in terms of its quality metrics, growth prospects, and valuation. And then we overlay a range of shorter horizon sentiment and momentum indicators, which give us a sort of certainty-uncertainty conviction type element to our overall stock selection. 

    You’ll probably find that most people understand this concept and what they do is they invest in a range of different investment managers that have different styles. The fact that we quantitatively can put all of this together in one portfolio means then we have risk control across the entire portfolio. 

    Buying and selling 

    MF: What do you look at closely when considering buying a stock?

    MC: We’ll actually model the company’s financial statements, looking at quality metrics – in particular their cash flow. We’ll look at growth. 

    When we look at growth, we take a slightly different approach. Yes, we are interested in the company’s top line growth metrics, but we’re also interested in the degree to which sales are growing faster than costs. So we’re looking for that incremental uplift, which for us gives us a better indication that there’s a positive surprise coming for a particular company. 

    When it comes to valuation, we take a range of different approaches whereby we try to model the company’s earnings from different starting points within their financial statements. We’re looking at the trend and consistency of their earnings, of their taxable income, of their free cash flow, their operating profit, their return on equity, for example. What that gives us is quite a robust metric that we can use to compare the valuation of different companies across different sectors in the marketplace. 

    Then, as I said, there’s a range of other sentiment, momentum, news-based metrics, which help us to have either higher certainty about those metrics. So for example, if we really do like a company, be it on quality growth or valuation, but we’re seeing that some of the shorter term metrics are quite negative or poor, then we’ll sort of ratchet back our expectations. Whereas if everything’s pointing in the same direction, then that’ll give us more confidence to actually increase our position.

    MF: What triggers you to sell a share?

    MC: Obviously if a company’s own metrics start to deteriorate. For example, if a company performs very well, it’s no longer attractive on valuation. And maybe we’re seeing that the kind of growth that the company is undertaking is poor quality and not leading to our expectation of increasing profitability. 

    But at the same time we’re looking also to see, even if a company stays still, if there’s another stock similar to it, similar industry. Because we try to keep a quite diversified portfolio that now starts to become more attractive. 

    Overlaid on top of all of that, we look at the individual tax parcel positions that we have in the portfolio. So that as we’re rebalancing we want to make sure that we’re not just unnecessarily churning and causing tax liabilities. Because we know that risk and return forecasts are uncertain, but when you actually realise a gain, the tax implications are certain. 

    So we try to do that quite complex trade-off in a very automated, very disciplined way.

    MF: Not many fund managers talk about capital gains tax implications, but it’s an important factor, isn’t it?

    MC: Absolutely. One of the key things, particularly for superannuation funds, you know that a capital gain is discounted if it’s held for more than 12 months. It’d be quite silly to actually sell a stock in a gain position, if you’ve been holding it for 11.5 months. There has to be something quite drastic to change in terms of your return expectations, to override having to pay 15% tax versus holding for two weeks and then getting a 33% reduction on that tax payment.

    What’s coming up?

    MF: Where do you think the world is heading at the moment?

    MC: I must admit, we were, and certainly I was, quite surprised at the degree to which the markets bounced back in March of 2020. 

    Of course they were supported by massive fiscal and monetary stimulus, which was coordinated across the entire world, and that is continuing today. So really what we’ve seen is the markets look through the earnings drop and out into 2022, 2023. 

    We see that there’s a lot of positive expectation already built into share prices. There are still corners of the marketplace where there are maybe more valuation type opportunities. 

    But in general the market is back – and from our perspective more fully priced. So that is the challenge – I think what could derail things is maybe a slower than expected rollout of vaccines or something associated with the fact that we can’t return back to pre-COVID type activity levels as soon as we’d expected.

    MF: Like if the vaccines were proven to be ineffective or not last very long?

    MC: That’s right. Or for that matter, if there’s simply a delay in being able to get that through populations, which means that countries remain locked down. While there may be domestic travel, then there’s probably no international travel associated with that. So that really is the risk. 

    What we’ve seen in the pricing of equity markets to date has been this extrapolation of very low rates almost forever. And we did see that at the end of 2018, when the US Fed did start [talking] about tapering their support, that equity markets did fall. 

    I think there’s a lot of what we might call long-duration type stocks. Stocks where profitability is expected to come, but probably in about 3 to 5 years’ time. That if there are expectations of increased interest rates, even in the next 2 or 3 years, then maybe their future profitability out to 2030 will start to be discounted to quite a high degree. 

    So some of the high-flying stocks that really now need about a decade of plain sailing to get their financial statements to be in line with their current price. There’s going to be a few risks to some of those stocks, maybe not delivering the returns that they have over the last 12 months.

    Overrated and underrated shares

    MF: What’s your most underrated stock at the moment?

    MC: One of the stocks we’ve had an eye on and we have a position in at the moment is Reliance Worldwide Corporation Ltd (ASX: RWC). They’re a plumbing business essentially – rather quite boring. They’re sort of behind the walls. You don’t really see their product. It just sort of happens in the background.

    If you look at the history of Reliance, while they’ve been around really for many decades, over the last 5, 10 years the company has been quite acquisitive, both in Australia and internationally. What we saw in their financial statements from last year is really a strong positioning in terms of all of those transactions that they’ve put together into the business – now actually starting to build momentum and causing incremental profit growth the way that we actually like to see it.

    We see that it’s a stock that currently is on track to probably double their earnings from 2018. And yet is still trading at 30% below the price that it traded at its highs in 2018. 

    We think it’s also going to be supported by fiscal spending and investment into construction over the next few years. And obviously their plumbing products will be in great demand. [That] really supports their growth here in Australia, in the United States and also a growing business through Europe. 

    So it’s one of the stocks that we think at the moment is underappreciated. They did have a very good half-year update the other day, which the market responded to quite positively. And we expect for that positive sentiment to continue in the near term.

    MF: When did you start buying into Reliance?

    MC: We started building up our position from October last year. We saw the outcome in the 30 June result, which was released in August, that already started to give us a positive signal. They then provided an update in October and that actually caused analysts in the marketplace to start revising up their earnings forecasts for ’21 and ’22… And that was when the stars aligned for our metrics to build up a position in the stock.

    MF: Plumbing never goes out of fashion, does it?

    MC: There’s a lot of truth in what you’re saying there. It does remind me a little bit of the 1999-2000 period, both here in Australia and offshore, where everybody was about clicks and order as opposed to bricks and mortar. 

    I think the one difference today is that maybe a lot of the old school businesses, certainly their growth profile is maybe not as strong as some of these IT and tech stocks. But if they are trading at an attractive valuation and can grow earnings meaningfully over the next 2 or 3 years, then I think they do have a part to play in people’s portfolios and can deliver the good returns.

    MF: What do you think is the most overrated stock at the moment?

    MC: There’s a stock called Afterpay Ltd (ASX: APT) in the buy now, pay later space. It’s had a very strong run and I think it is one of those stocks that from a valuation perspective, we think it now really needs that decade of runway to be able to get its fundamentals and financials to be in line with its price expectations. 

    That’s not to say that it can’t do that, and it can remain and become a market leader. I think just the incremental return that’s available to investors as the company goes down that path is probably not as strong as what we can see in other places. 

    I’m not necessarily talking about IT [as overrated], because there are stocks in there that we do like. 

    But even a company like Nextdc Ltd (ASX: NXT) that is running data centres, again, we see that it has probably had a re-rating because of its participation in that tech sector. We do have concerns that maybe its growth profile is not as strong. 

    Also, one of the things that we find very important and we look at is the metrics of stocks in terms of its environmental, social, and governance (ESG) practices and risks. One of the risks we do see for NextDC is its energy utilisation. Data centres need power, they need air conditioning – you can have solar panels on the roof, but unfortunately they don’t work at night time. 

    So there is a bit of transition work to be done by some of those data centre companies to be more carbon efficient. 

    MF: For non-software tech businesses like that, it’s capital-intensive to run, isn’t it?

    MC: Exactly right. So you do need that physical location and obviously that carries its own costs both in setup and then maintenance going forward.

    Looking back

    MF: Which stock are you most proud of from a past purchase?

    MC: I’ve got a couple… The first one is actually Fortescue Metals Group Limited (ASX: FMG). Iron ore stock, yes, it is the market darling. It’s up over 100% last year, from $10.88 through to $24 plus more than $2 if you include the tax credits on the dividend.

    What we saw within our metrics, and I think the timing of it was quite important, and that is that we’d seen the cash flow generation steadily increasing. What our modeling was telling us is that the cap-ex that had been put into the business was obviously good quality capital expenditure. 

    Now the company was in a very strong position to be able to leverage increased prices in iron ore into direct profitability. Sometimes companies need that price increase to justify their existence, but Fortescue put themselves in a position where price rises were just going to essentially throw off a great deal of cash, which has certainly transpired.

    We did have a little bit of uncertainty with valuation going into March, but then what happened was in March there was guidance provided by the company that their activities through the COVID period they felt were going to be unchanged. And that then sparked off a range of upgrades through April and May, which then saw the price take off thereafter. 

    We’d already had a position. We saw that the company had very strong growth potential… Then when things got quite uncertain there in March, we essentially were increasing our position because we felt that if things remained unchanged for them, then the stock was going to deliver quite great returns. 

    The stock was still at $13.75 at 30 June. So it really doubled in price over the period of 6 months.

    It was a great example of looking through the noise of the marketplace at the time, and looking through to the fundamentals. Looking through to the positive sentiment and expectations going forward. And it ended up being the best individual performer in the portfolio for the year.

    MF: You’re still holding?

    MC: Yeah, we are still holding. One of the interesting things about the way we run the Tax Effective Portfolio is that when we get new cash flow from new investors into the portfolio, we actually re-optimise to determine a specific trade list for each cash flow. 

    And so what it’s actually doing is actually reducing the active position in Fortescue in a very tax-effective way. We never have to sell a share of the stock, but new investor capital helps to downlight that active position because we don’t just buy naively across the entire portfolio. We actually look at each cash flow on its merits and what we find attractive at any given point in time. We’ll focus more of the [new] capital into the names which we find most attractive today, and then allow the other positions to just naturally reduce over time. 

    During March and April when markets fell, we actually did a lot more turnover because it was actually quite tax-efficient to reposition the portfolio – because we could realise losses, which could then offset the tax payments that would have been made on dividends.

    So there’s a lot of trade offs that go into the process. That’s our edge as a quantitative manager, is to be able to trade off all of these different moving pieces of information, and then come up with a nicely diversified portfolio with a range of different style drivers, all acting at the same time.

    MF: What’s the second stock that you’re proud of?

    MC: The other one was a story on real estate. This was more a bit of a longer term trend. We’ve seen through our metrics that a lot of the retail shopping centre businesses were starting to fall off in their profit growth. And we saw this being driven by the fact that pretty much every square metre of Westfield shopping centre (Scentre Group (ASX: SCG)) was devoted to some kind of activity. 

    So the scope for continuing to up the revenue within that current square meterage was then starting to be reduced. We saw that the growth prospects for some of those companies weren’t as strong, and we started repositioning to where we saw better opportunities in particular with stocks like Goodman Group (ASX: GMG).

    Admittedly, the whole COVID pandemic lockdown accelerated a number of things. The lockdown within shopping centres meant that we were under-invested in those names, which was positive. Then with Goodman and their industrial portfolio picking up on delivery, and warehousing growth with Amazon.com Inc (NASDAQ: AMZN) here in Australia. 

    But more importantly, Goodman actually has a very strong global business. So in one aspect we saw the growth in Goodman and deteriorating growth in retail. Through the last 12 months that’s been a positive thematic that’s played out. Maybe not for the reasons that we’d expected two years ago, but COVID accelerated that repricing within those stocks.

    MF: Is there a move that you regret from the past? For example, a missed opportunity or buying a stock at the wrong timing or price.

    MC: I do look at Afterpay and say, “In many ways at $10 in mid-March it was a value stock”. It’s so easy to say now in hindsight, I must admit it’s a little bit humbling when the stock that you choose in a sector, like Xero Limited (ASX: XRO), goes up a 100% and it’s the under-performer in the sector by a factor of 10!

    Having lived through and managed an Australian small caps product through 1999 and 2000, I’ve seen how the market can re-price some of these names. In some ways we were a little bit slow, particularly in this portfolio, to get a position. We currently do [hold Afterpay], but we are underweight – it’s more there for risk purposes. 

    That’s probably the one stock that, if we had our timing in, we might have had a little bit more invested in it in April and May, of last year.

    We remain disciplined to our investment process. From a quality perspective its cash flow generation and lack of profitability is a red X for us. It’s hard to obviously get a value on the stock, but even across our metrics it doesn’t look like a valuation opportunity. 

    Growth does seem to be turning more positive of late. That’s why we’ve taken a position over the last 6 months in the stock. Momentum has been quite strong… And the stock has responded very well or the market has responded to news and announcements from the company. 

    But we still see that there is a divergence across analysts in the marketplace. You know, some believing that the stock is headed to $200, others believing that it’s probably more fair value at $30. No doubt, the truth is somewhere in between. Exactly which side is going to win out, we’ll just have to wait and see.

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Tony Yoo owns shares of AFTERPAY T FPO, Amazon, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Amazon. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Reliance Worldwide Limited and Xero and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Amazon and Reliance Worldwide Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Forget growth or value: Here’s a neutral way to pick shares appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3pB191v

  • 2 top ETFs to buy for February 2021

    Block letters 'ETF' on yellow/orange background with pink piggy bank

    There are a few exchange-traded funds (ETFs) that could be worth looking at in February 2021.

    An ETF allows investors to buy a large group of shares in a single trade, providing diversification.

    Here are two ETFs that could be worth looking at:

    Betashares Nasdaq 100 ETF (ASX: NDQ)

    This has been one of the highest-performing large ETFs over the past few years.

    The idea of this is to give investors exposure to 100 of the largest businesses in the US on the NASDAQ stock exchange.

    This ETF is weighted towards technology, with almost half of the portfolio invested in information technology. Another 19% of the ETF is invested in consumer discretionary businesses and 18.6% is invested in communication services. Healthcare makes up 6.5% of the portfolio and industrials is responsible for 1.9%.

    Looking at the holdings in the portfolio, there is heavy exposure to many of the biggest US technology businesses: Apple is 12.1% of the portfolio, Microsoft is 9.4% of the portfolio, Amazon is 8.6% of the portfolio, Alphabet is 6.3% of the portfolio, Tesla is 5% of the portfolio and Facebook is 3.3% of the portfolio.

    Betashares Nasdaq 100 ETF also has investments in other technology businesses like Nvidia, PayPal, Intel, Netflix, Adobe, Advanced Micro Devices, Intuit and Applied Materials.

    The ETF isn’t just about technology companies, it has many non-tech names in the portfolio like PepsiCo, Costco, Starbucks, Intuitive Surgical, Moderna and Monster Beverage.

    There are also a couple of Asian giants listed on the NASDAQ, so they are within the ETF’s portfolio too including Baidu and JD.com.

    The annual management fee of this ETF is 0.48% per annum.

    Looking at the net returns, after fees, of the ETF shows a 13.3% net return over the past six months, a 34.8% net return over the past year, a 27.4% per annum net return over the last three years and a 21.4% net return per annum since inception in May 2015.

    VanEck Vectors Morningstar Wide Moat ETF (ASX: MOAT)

    This ETF is about giving investors exposure to a diversified portfolio of attractively priced US companies with sustainable competitive advantages according to Morningstar’s equity research team.

    The ‘wide moat’ part of the name comes from the fact that there’s a focus on quality US companies Morningstar believes possess sustainable competitive advantages, or ‘wide economic moats’.

    To make it into the VanEck Vectors Morningstar Wide Moat ETF portfolio, those target companies need to be trading at attractive prices relative to Morningstar’s estimate of fair value, after a rigorous equity research process.

    The entire portfolio is invested in businesses listed in the US, though the underlying earnings comes from multiple countries.

    However, the investments are spread across a number of sectors. Those industries with a weighting of more than 5% include: health care (18.8%), financials (17.6%), information technology (17.5%), industrials (12.2%), consumer staples (10.8%), consumer discretionary (8.5%), communication services (5.5%) and materials (5.2%).

    In terms of the actual holdings of VanEck Vectors Morningstar Wide Moat ETF, as of 29 January 2021 it had 49 holdings. The biggest positions were: Corteva, Dominion Energy, Emerson Electric, General Dynamics, Gilead Sciences, Alphabet, Guidewire Software, Intel and John Wiley and Sons.

    After the annual management fee cost of 0.49% per annum, the net returns over the past five years have been 16.6% per annum. The index that the ETF tracks has made returns of almost 19% per annum over the last decade.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended BETANASDAQ ETF UNITS. The Motley Fool Australia has recommended VanEck Vectors Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 top ETFs to buy for February 2021 appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3oFincS

  • Why is the Hawkstone Mining (ASX:HWK) share price flying 8%?

    flying asx share price represented by hawk soaring through the air

    Hawkstone Mining Ltd (ASX: HWK) shares are flying higher today. At the time of writing, the Hawkstone share price has soared 8.3% to 5.2 cents after climbing as high as 5.5 cents in morning trade. 

    This compares to a 0.58% gain on the All Ordinaries Index (ASX: XAO). And it’s enough to put the Hawkstone share price up 420% in 2021. In fact, you could have bagged those 420% gains by buying Hawkstone shares as recently as Thursday 14 January. At the time, Hawkstone Mining was trading for just 1 cent per share. 

    Why is the Hawkstone Mining share price on the rise?

    A big surge in the Hawkstone share price late last week came thanks to positive news from the company’s lithium operations. However, the United States-focused, diversified minerals explorer’s intraday gains today look to be driven by gold.

    In an update to the ASX this morning, Hawkstone Mining reported “spectacular grades” from its Devil’s Canyon Gold Project, located in the Carline trend in Nevada, US.

    This comes after the company completed additional rock sampling, airborne drone magnetics and structural mapping at the project.

    If you’re interested in a few of the technical results, the airborne magnetic survey identified additional geophysical features including “magnetite skarn alteration at lithological contacts and along structures”, and “zones of magnetite destruction possibly related to later mineralising events”.

    The company noted the project is just 20 km east of Kinross Gold Corporation (NYSE: KGC)‘s Bald Mountain Mine, which has a resource of 5.9 million ounces of gold. It also reported that the Carlin trend has already produced more than 195 million ounces of gold. Clearly, Hawkstone is hoping to add to that figure.

    What did management say?

    Addressing the drill results, Hawkstone Managing Director Paul Lloyd said:

    These highly encouraging rock sample assay results from our Devil’s Canyon Project further confirm and extend mineralised areas identified from previous work, which when combined with the recently completed aeromagnetic survey data, show several areas for high priority follow-up.

    These high-grade results reinforce our business model of exploring for world class gold deposits in the Western United States adjacent to large gold resources or producing gold mines. This is in addition to our Big Sandy Sedimentary Lithium Project in Arizona that remains the company’s primary focus.

    The company is continuing with drill targeting work and stated it expects to commence the maiden drilling program at Devil’s Canyon in the 2021 US northern field season.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why is the Hawkstone Mining (ASX:HWK) share price flying 8%? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2Lasnxc

  • Why the PolyNovo (ASX:PNV) share price is pushing higher

    It has been an eventful day for the PolyNovo Ltd (ASX: PNV) share price on Monday.

    After dropping as much as much as 4% lower in morning trade, the medical device company’s shares are now in the black.

    The PolyNovo share price is currently up 1% to $2.67.

    Why is the PolyNovo share price pushing higher today?

    As well as getting a lift from a rebound by the Australian share market this afternoon, the release of an announcement has given the PolyNovo share price a boost today.

    That announcement reveals that the company has continued its expansion in the European market by entering the Italian market. This follows announcements in January which revealed that the company had expanded into Poland and Turkey.

    According to the release, PolyNovo is entering the Italian medical device market through the appointment of Medival as its distribution partner in the country.

    Medival is focused on providing advanced and innovative medical devices to critical care and surgical specialties. It has an established customer base throughout Italy, accessing approximately 1500 plastic surgeons and have 25 reps on the road and one dedicated product manager.

    The company’s NovoSorb BTM rounds out its product portfolio, ensuring it can offer its surgeons a complete range.

    The Italian opportunity

    Management notes that Italy is the fourth largest medical device market in Europe and worth ~US$10 billion per annum. It also points out that the Italian market is innovative and mature, with a high demand for advanced products.

    It appears to believe this makes it a great market for its exciting technology, NovoSorb BTM. It is a dermal scaffold for the regeneration of the skin when lost through extensive surgery or burn and offers improved functional and cosmetic outcomes for patients.

    PolyNovo’s Managing Director, Paul Brennan, commented: “We are extremely excited to enter Italy through Medival. The Italian market is very sophisticated, and we think it will value innovative, quality medical technologies like ours. The country is important both geographically and commercially and is a major step forward in our European strategy. We will now be servicing surgeons who are a very influential throughout Europe.”

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the PolyNovo (ASX:PNV) share price is pushing higher appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3t9k1XT

  • Wisr (ASX:WZR) share price pops following half-year results announcement

    Woman in yellow jumper with excited expression holds laptop open with one fist raised

    The WISR Ltd (ASX: WZR) share price is up nearly 3% following release of the company’s first half FY21 results today and is currently trading at 19 cents. The Wisr share price has fallen roughly 30% over the previous 12-month period.

    Wisr is a consumer lending and fintech company. In today’s results presentation, the company reiterated its aim to ‘aggressively capture market share’ in the consumer lending market. Wisr intends to ‘reinvent’ consumer lending by offering what it labels as fairer rates, a better loan experience, and financial literacy education.

    Here are some highlights from Wisr’s first half FY21 update.

    Wisr’s first half highlights

    The company reported first half FY21 revenue of $10 million. This is a 354% increase compared to Wisr’s  first half FY20 revenue of $2.2 million.

    Overall cash earnings before interest, tax, depreciation and amortisation (EBITDA) for the period was $6.5 million. This was a 6% improvement compared to $6.9 million EBITDA reported for the prior corresponding period.

    Operating expenses (Opex) increased by 59% during the first half of FY21. The company advised that this is in line with its management plan. Wisr pointed to the 59% Opex increase in relation to its 354% revenue increase, stating the two compare ‘very favourably’ and are in line with business deliverables.

    Wisr reports that it currently has over $390.5 million in loans written to date. The company’s loan originations rose 166% when comparing this half to the prior corresponding period. Loan originations for the period came in at $145.7 million.

    Wisr CEO commentary

    Commenting on the first half achievements, Wisr CEO Mr. Anthony Nantes said:

    We have seen a substantial step-change in operating capability in the last six months. Our H1FY21 results delivered a significant 354% uplift in revenue while reducing overall Cash EBTDA loss by 6%, compared to this same period last financial year.

    Investments in talent and technology, planned at the time of our January 2020 capital raise but deferred in response to COVID-19, have now been made. This means that increases in operating cost base will be more incremental in the medium term, resulting in significant operating leverage as revenue continues to grow strongly in-line with the growth of our loan book.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Wisr (ASX:WZR) share price pops following half-year results announcement appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3pOuFkN

  • ASX stock of the day: Why Oneview Healthcare (ASX:ONE) shares are rocketing 140% today

    Investor riding a rocket blasting off over a share price chart

    Oneview Healthcare PLC (ASX: ONE) shares are on fire today, rocketing almost 140% at the time of writing to 10 cents per share. The Oneview share price finished up trading on Friday at just 4.2 cents, but opened this morning at 5 cents before climbing as high as 12 cents soon after open. Even though Oneview shares have since cooled from these highs, a nearly 140% intra-day return is still one for the books.

    So what is Oneview Healthcare? And (perhaps more importantly) why are Oneview shares worth 140% more today than they were last week?

    One-view to a room

    Oneview Healthcare is a healthcare company (shocking, I know) that aims to “build technology that fosters holistic, relationship-centred care”. The company was founded in 2012 and is listed on the ASX, but incorporated in Ireland (hence the ‘plc’). Oneview operates a software-as-a-service (Saas) business model. It sells access to its software platforms, which help healthcare workers deliver better and more tailored bedside care, including to “support COVID-19 response”.

    Patients and carers can use the software for performing functions like ordering customised meals, video chatting with family or friends, requesting medical attention, accessing entertainment services, and communicating with others for telehealth appointments and similar consultations.

    The company’s software is used across the United States, Australia, the Middle East and Asia in 55 hospitals spanning 18 different cities. Oneview lists New South Wales Health, Queensland Health, and The Sydney Children’s Hospital Network as customers, as well as several large US clients.

    Back in August, Oneview reported that the number of beds equipped with its software had grown by 30% year on year in the first half of 2020. It also reported recurring revenue was up 21% to 2.6 million euros. It wasn’t all good news though, total revenues fell 15% year on year, largely due to the impact of the pandemic.

    Why are Oneview shares racing higher today?

    Today’s stunning moves in the Oneview share price appear to be the result of a company announcement released to the ASX this morning just before market open. In the release, Oneview told investors the company has signed a “distribution agreement” with Samsung SDS America Inc (Samsung SDSA), which is “the enterprise IT solutions provider of Samsung“, to offer a “bundled solution for bedside digital services for patients in the United States”.

    This agreement will reportedly allow Samsung SDSA to distribute Oneview’s Cloud Start product to “healthcare-focused enterprise resellers” beginning this month. Cloud Start runs exclusively on Samsung tablets and was reportedly deployed across four hospitals in New York at the “height of the pandemic” last year. Evidently, the company’s technology was well-received.

    Oneview CEO James Fitter had this to say on the deal: 

    Our move to the cloud accelerates speed to market and opens new possibilities for distribution, making it faster, easier and lower-cost for end-customers to benefit from the digital platform at the bedside. Never has this need been so apparent. Our partnership with Samsung provides a unique opportunity to address new virtual models of care and provide the solution for Samsung SDSA to enhance the value proposition for their reseller network.

    Clearly, this agreement has investors pretty excited, judging by today’s eye-popping gains in the Oneview share price.

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX stock of the day: Why Oneview Healthcare (ASX:ONE) shares are rocketing 140% today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3oyyicV